Genetic Background Predicts Uveal Melanoma Patients' Outcomes.

Area of Science:

• Ophthalmology
• Genetics
• Oncology

Background:

• Single nucleotide polymorphisms (SNPs) in IRF4 and HERC2 are linked to chromosome 3 disomy (D3) or monosomy (M3) in uveal melanoma (UM).
• Understanding the genetic basis of UM is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the association between germline genetics (IRF4 and HERC2 SNPs) and uveal melanoma (UM) patient outcomes.
• To evaluate the potential of a derived genetic signature for UM prognosis.

Main Methods:

• A cohort study involving 1339 UM patients analyzed the impact of IRF4 and HERC2 SNPs on survival using Kaplan-Meier and Cox regression.
• Generalized linear models assessed SNP associations with UM subtypes and iris color.
• A classifier was trained and validated to predict UM subtypes and survival.

Main Results:

• IRF4 rs12203592-T and HERC2 rs12913832-G SNPs were associated with improved and worsened survival, respectively, primarily via chromosome 3 status.
• SNP associations with UM subtypes (D3/M3) were largely independent of iris pigmentation.
• A genetic classifier predicted chromosome 3 status and survival but did not outperform established clinical prognostic features.

Conclusions:

• Inherited polymorphisms in IRF4 and HERC2 are independently associated with UM subtype and prognosis.
• Current SNP-based classifiers do not yet outperform established prognostic models for UM.
• Further research may refine genetic markers for UM risk stratification.